Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells

Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind...

書誌詳細
主要な著者:	Engelen, SE, Ververs, FA, Markovska, A, Lagerholm, BC, Kraaijenhof, JM, Yousif, LI, Zurke, Y-X, Gulersonmez, CM, Kooijman, S, Goddard, M, van Eijkeren, RJ, Jervis, PJ, Besra, GS, Haitjema, S, Asselbergs, FW, Kalkhoven, E, Ploegh, HL, Boes, M, Cerundolo, V, Hovingh, GK, Salio, M, Stigter, EC, Rensen, PC, Monaco, C, Schipper, HS
フォーマット:	Journal article
言語:	English
出版事項:	American Society for Clinical Investigation 2023

類似資料

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
著者:: Suzanne E. Engelen, 等
出版事項: (2023-05-01)

Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
著者:: Veerapen, N, 等
出版事項: (2011)

Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation.
著者:: Veerapen, N, 等
出版事項: (2011)

Immunometabolic factors in adolescent chronic disease are associated with Th1 skewing of invariant Natural Killer T cells
著者:: Ververs, FA, 等
出版事項: (2021)

Towards multivalent CD1d ligands: Synthesis and biological activity of homodimeric α-galactosyl ceramide analogues
著者:: Jervis, P, 等
出版事項: (2012)

Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.
著者:: Jervis, P, 等
出版事項: (2012)

Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
著者:: Engelen, SE, 等
出版事項: (2022)

Invariant NKT Cell at the Interface between Innate and Adaptive Immunity
著者:: Salio, M, 等
出版事項: (2011)

Linking inflammation to natural killer T cell activation
著者:: Salio, M, 等
出版事項: (2009)

Harnessing NKT cells for therapeutic applications.
著者:: Cerundolo, V, 等
出版事項: (2007)

Viral immunity: cross-priming with the help of TLR3.
著者:: Salio, M, 等
出版事項: (2005)

Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition
著者:: Jordan M. Kraaijenhof, 等
出版事項: (2024-06-01)

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells
著者:: A. Markovska, 等
出版事項: (2024-09-01)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
著者:: Gadola, S, 等
出版事項: (2006)

Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation.
著者:: Salio, M, 等
出版事項: (2007)

The year in cardiovascular medicine 2020: digital health and innovation [Год в сердечно-сосудистой медицине, 2020 г.: цифровое здравоохранение и инновации]
著者:: Antoniades, C, 等
出版事項: (2021)

Harnessing the power of invariant natural killer T cells in cancer immunotherapy
著者:: Bedard, M, 等
出版事項: (2017)

The immune modulating properties of mucosal-associated invariant T cells
著者:: Ioannidis, M, 等
出版事項: (2020)

Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells.
著者:: Salio, M, 等
出版事項: (2000)

T cell receptors get back to basics.
著者:: Jones, E, 等
出版事項: (2007)

Dendritic cells: a journey from laboratory to clinic.
著者:: Cerundolo, V, 等
出版事項: (2004)

Recent advances in processing and presentation of CD1 bound lipid antigens.
著者:: Salio, M, 等
出版事項: (2010)

Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
著者:: Jervis, P, 等
出版事項: (2013)

A single-cell genomic based investigation of immune cells in the aorta and adipose tissue during metabolic disease progression
著者:: Zurke, YX
出版事項: (2023)

B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo.
著者:: Barral, P, 等
出版事項: (2008)

Harnessing invariant NKT cells in vaccination strategies.
著者:: Cerundolo, V, 等
出版事項: (2009)

Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.
著者:: Gadola, S, 等
出版事項: (2002)

Potential role for CD1d restricted T-cells in the immunopathology of sarcoidosis
著者:: Ho, L, 等
出版事項: (2003)

Essential role for autophagy during invariant NKT cell development
著者:: Salio, M, 等
出版事項: (2014)

Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar
著者:: Preiss, D, 等
出版事項: (2020)

Immunotherapy of colorectal cancer.
著者:: Smith, C, 等
出版事項: (2002)

A closer look at CD1d molecules: new horizons in studying NKT cells.
著者:: Stronge, V, 等
出版事項: (2007)

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.
著者:: Palmowski, M, 等
出版事項: (2002)

Biology of CD1- and MR1-restricted T cells.
著者:: Salio, M, 等
出版事項: (2014)

Genetic analysis of emerging risk factors in coronary artery disease
著者:: van Iperen, E, 等
出版事項: (2016)

Low‐Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific
著者:: Arjen J. Cupido, 等
出版事項: (2022-06-01)

Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.
著者:: Quiroga, I, 等
出版事項: (2006)

Lack of dendritic cell maturation by the plant toxin ricin.
著者:: Smith, D, 等
出版事項: (2004)

Cerundolo et al. respond
著者:: De Santo, C, 等
出版事項: (2011)

Structural and functional aspects of lipid binding by CD1 molecules.
著者:: Silk, J, 等
出版事項: (2008)